179 related articles for article (PubMed ID: 18354195)
1. Combined CXCR3/CCR5 blockade attenuates acute and chronic rejection.
Schnickel GT; Bastani S; Hsieh GR; Shefizadeh A; Bhatia R; Fishbein MC; Belperio J; Ardehali A
J Immunol; 2008 Apr; 180(7):4714-21. PubMed ID: 18354195
[TBL] [Abstract][Full Text] [Related]
2. Role of CXCR3 and CCR5 in allograft rejection.
Schnickel GT; Hsieh GR; Garcia C; Shefizadeh A; Fishbein MC; Ardehali A
Transplant Proc; 2006 Dec; 38(10):3221-4. PubMed ID: 17175228
[TBL] [Abstract][Full Text] [Related]
3. Absence of recipient CCR5 promotes early and increased allospecific antibody responses to cardiac allografts.
Amano H; Bickerstaff A; Orosz CG; Novick AC; Toma H; Fairchild RL
J Immunol; 2005 May; 174(10):6499-508. PubMed ID: 15879153
[TBL] [Abstract][Full Text] [Related]
4. A novel small-molecule compound targeting CCR5 and CXCR3 prevents acute and chronic allograft rejection.
Akashi S; Sho M; Kashizuka H; Hamada K; Ikeda N; Kuzumoto Y; Tsurui Y; Nomi T; Mizuno T; Kanehiro H; Hisanaga M; Ko S; Nakajima Y
Transplantation; 2005 Aug; 80(3):378-84. PubMed ID: 16082334
[TBL] [Abstract][Full Text] [Related]
5. CCR5 blockade in combination with rapamycin prolongs cardiac allograft survival in mice.
Li J; Zhang K; Ye P; Wang S; Xia J
Clin Exp Immunol; 2009 Sep; 157(3):437-45. PubMed ID: 19664153
[TBL] [Abstract][Full Text] [Related]
6. Monokine induced by IFN-gamma is a dominant factor directing T cells into murine cardiac allografts during acute rejection.
Miura M; Morita K; Kobayashi H; Hamilton TA; Burdick MD; Strieter RM; Fairchild RL
J Immunol; 2001 Sep; 167(6):3494-504. PubMed ID: 11544343
[TBL] [Abstract][Full Text] [Related]
7. Antibody-mediated rejection of cardiac allografts in CCR5-deficient recipients.
Nozaki T; Amano H; Bickerstaff A; Orosz CG; Novick AC; Tanabe K; Fairchild RL
J Immunol; 2007 Oct; 179(8):5238-45. PubMed ID: 17911609
[TBL] [Abstract][Full Text] [Related]
8. CXCR3 and CCR5 positive T-cell recruitment in acute human renal allograft rejection.
Panzer U; Reinking RR; Steinmetz OM; Zahner G; Sudbeck U; Fehr S; Pfalzer B; Schneider A; Thaiss F; Mack M; Conrad S; Huland H; Helmchen U; Stahl RA
Transplantation; 2004 Nov; 78(9):1341-50. PubMed ID: 15548973
[TBL] [Abstract][Full Text] [Related]
9. IP-10-induced recruitment of CXCR3 host T cells is required for small bowel allograft rejection.
Zhang Z; Kaptanoglu L; Tang Y; Ivancic D; Rao SM; Luster A; Barrett TA; Fryer J
Gastroenterology; 2004 Mar; 126(3):809-18. PubMed ID: 14988835
[TBL] [Abstract][Full Text] [Related]
10. Suppression of acute and chronic cardiac allograft rejection in mice by inhibition of chemokine receptor 5 in combination with cyclosporine A.
Li J; Xia J; Zhang K; Xu L
J Surg Res; 2009 Nov; 157(1):81-90. PubMed ID: 19577762
[TBL] [Abstract][Full Text] [Related]
11. Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection.
Yun JJ; Whiting D; Fischbein MP; Banerji A; Irie Y; Stein D; Fishbein MC; Proudfoot AE; Laks H; Berliner JA; Ardehali A
Circulation; 2004 Feb; 109(7):932-7. PubMed ID: 14757698
[TBL] [Abstract][Full Text] [Related]
12. Blocking of CCR5 and CXCR3 suppresses the infiltration of macrophages in acute renal allograft rejection.
Kakuta Y; Okumi M; Miyagawa S; Tsutahara K; Abe T; Yazawa K; Matsunami K; Otsuka H; Takahara S; Nonomura N
Transplantation; 2012 Jan; 93(1):24-31. PubMed ID: 22124337
[TBL] [Abstract][Full Text] [Related]
13. The role of CC chemokine receptor 5 (CCR5) in islet allograft rejection.
Abdi R; Smith RN; Makhlouf L; Najafian N; Luster AD; Auchincloss H; Sayegh MH
Diabetes; 2002 Aug; 51(8):2489-95. PubMed ID: 12145162
[TBL] [Abstract][Full Text] [Related]
14. Serial changes in the expression of CXCR3 and CCR5 on peripheral blood lymphocytes following human renal transplantation.
Inston N; Drayson M; Ready A; Cockwell P
Exp Clin Transplant; 2007 Dec; 5(2):638-42. PubMed ID: 18194114
[TBL] [Abstract][Full Text] [Related]
15. Requirement of the chemokine receptor CXCR3 for acute allograft rejection.
Hancock WW; Lu B; Gao W; Csizmadia V; Faia K; King JA; Smiley ST; Ling M; Gerard NP; Gerard C
J Exp Med; 2000 Nov; 192(10):1515-20. PubMed ID: 11085753
[TBL] [Abstract][Full Text] [Related]
16. Chemokine receptor blockade with a synthetic nonpeptide compound attenuates cardiac allograft vasculopathy.
Bastani S; Sherman W; Schnickel GT; Hsieh GR; Bhatia R; Fishbein MC; Ardehali A
Transplantation; 2009 Oct; 88(8):995-1001. PubMed ID: 19855245
[TBL] [Abstract][Full Text] [Related]
17. Natural killer cells play a critical role in mediating inflammation and graft failure during antibody-mediated rejection of kidney allografts.
Kohei N; Tanaka T; Tanabe K; Masumori N; Dvorina N; Valujskikh A; Baldwin WM; Fairchild RL
Kidney Int; 2016 Jun; 89(6):1293-306. PubMed ID: 27165816
[TBL] [Abstract][Full Text] [Related]
18. Prolongation of cardiac and islet allograft survival by a blocking hamster anti-mouse CXCR3 monoclonal antibody.
Uppaluri R; Sheehan KC; Wang L; Bui JD; Brotman JJ; Lu B; Gerard C; Hancock WW; Schreiber RD
Transplantation; 2008 Jul; 86(1):137-47. PubMed ID: 18622291
[TBL] [Abstract][Full Text] [Related]
19. In the absence of natural killer cell activation donor-specific antibody mediates chronic, but not acute, kidney allograft rejection.
Yagisawa T; Tanaka T; Miyairi S; Tanabe K; Dvorina N; Yokoyama WM; Valujskikh A; Baldwin WM; Fairchild RL
Kidney Int; 2019 Feb; 95(2):350-362. PubMed ID: 30503624
[TBL] [Abstract][Full Text] [Related]
20. Absence of allograft ICAM-1 attenuates alloantigen-specific T cell priming, but not primed T cell trafficking into the graft, to mediate acute rejection.
Zhang QW; Kish DD; Fairchild RL
J Immunol; 2003 Jun; 170(11):5530-7. PubMed ID: 12759430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
